Literature DB >> 10195105

Two sites of action for synapsin domain E in regulating neurotransmitter release.

S Hilfiker1, F E Schweizer, H T Kao, A J Czernik, P Greengard, G J Augustine.   

Abstract

Synapsins, a family of synaptic vesicle proteins, have been shown to regulate neurotransmitter release; the mechanism(s) by which they act are not fully understood. Here we have studied the role of domain E of synapsins in neurotransmitter release at the squid giant synapse. Two squid synapsin isoforms were cloned and found to contain a carboxy (C)-terminal domain homologous to domain E of the vertebrate a-type synapsin isoforms. Presynaptic injection of a peptide fragment of domain E greatly reduced the number of synaptic vesicles in the periphery of the active zone, and increased the rate and extent of synaptic depression, suggesting that domain E is essential for synapsins to regulate a reserve pool of synaptic vesicles. Domain E peptide had no effect on the number of docked synaptic vesicles, yet reversibly inhibited and slowed the kinetics of neurotransmitter release, indicating a second role for synapsins that is more intimately associated with the release process itself. Thus, synapsin domain E is involved in at least two distinct reactions that are crucial for exocytosis in presynaptic terminals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10195105     DOI: 10.1038/229

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  54 in total

Review 1.  Proteins involved in synaptic vesicle trafficking.

Authors:  G J Augustine; M E Burns; W M DeBello; S Hilfiker; J R Morgan; F E Schweizer; H Tokumaru; K Umayahara
Journal:  J Physiol       Date:  1999-10-01       Impact factor: 5.182

2.  Tonically active protein kinase A regulates neurotransmitter release at the squid giant synapse.

Authors:  S Hilfiker; A J Czernik; P Greengard; G J Augustine
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

Review 3.  Synapsins as regulators of neurotransmitter release.

Authors:  S Hilfiker; V A Pieribone; A J Czernik; H T Kao; G J Augustine; P Greengard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

4.  Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression.

Authors:  Erkang Fei; Xiaochuan Ma; Cuiqing Zhu; Ting Xue; Jie Yan; Yuxia Xu; Jiangning Zhou; Guanghui Wang
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

5.  Physical mobilization of secretory vesicles facilitates neuropeptide release by nerve growth factor-differentiated PC12 cells.

Authors:  Yuen-Keng Ng; Xinghua Lu; Edwin S Levitan
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

6.  Synapsin II Regulation of GABAergic Synaptic Transmission Is Dependent on Interneuron Subtype.

Authors:  Pedro Feliciano; Heidi Matos; Rodrigo Andrade; Maria Bykhovskaia
Journal:  J Neurosci       Date:  2017-01-13       Impact factor: 6.167

7.  Cooperative regulation of neurotransmitter release by Rab3a and synapsin II.

Authors:  William L Coleman; Maria Bykhovskaia
Journal:  Mol Cell Neurosci       Date:  2010-03-23       Impact factor: 4.314

8.  Structural domains involved in the regulation of transmitter release by synapsins.

Authors:  Sabine Hilfiker; Fabio Benfenati; Frédéric Doussau; Angus C Nairn; Andrew J Czernik; George J Augustine; Paul Greengard
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

9.  Synapsin II and calcium regulate vesicle docking and the cross-talk between vesicle pools at the mouse motor terminals.

Authors:  William L Coleman; Cynthia A Bill; Fatma Simsek-Duran; György Lonart; Dmitry Samigullin; Maria Bykhovskaia
Journal:  J Physiol       Date:  2008-07-31       Impact factor: 5.182

10.  Regulation of transmitter release by synapsin II in mouse motor terminals.

Authors:  Dmitry Samigullin; Cynthia A Bill; William L Coleman; Maria Bykhovskaia
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.